Device and method for monitoring of absolute oxygen saturation and tissue hemoglobin concentration
    6.
    发明授权
    Device and method for monitoring of absolute oxygen saturation and tissue hemoglobin concentration 有权
    用于监测绝对氧饱和度和组织血红蛋白浓度的装置和方法

    公开(公告)号:US09044181B2

    公开(公告)日:2015-06-02

    申请号:US14106905

    申请日:2013-12-16

    Abstract: A method and medical device for detecting signals that detects emitted light scattered by a volume of tissue delivered along a first pathway at a plurality of wavelengths to generate corresponding first detected light intensity output signals, detects emitted light scattered by the volume of tissue delivered along a second pathway different from the first pathway at a plurality of wavelengths to generate corresponding second detected light intensity output signals, determines whether a difference between the emitted light detected along the first pathway and the emitted light detected along the second pathway is greater than a predetermined threshold, and alters sensing by the device in response to the determining whether a difference is greater than the predetermined threshold.

    Abstract translation: 一种用于检测信号的方法和医疗装置,其检测由沿着第一路径以多个波长传送的组织体积散射的发射光,以产生相应的第一检测到的光强度输出信号,以检测由沿着 在多个波长处与第一路径不同的第二路径以产生相应的第二检测光强度输出信号,确定沿着第一路径检测的发射光与沿着第二路径检测的发射光之间的差是否大于预定阈值 并且改变响应于确定差异是否大于预定阈值的设备的感测。

    Method and apparatus for cardiac protection pacing
    7.
    发明授权
    Method and apparatus for cardiac protection pacing 有权
    用于心脏起搏的方法和装置

    公开(公告)号:US08855762B2

    公开(公告)日:2014-10-07

    申请号:US13721796

    申请日:2012-12-20

    Abstract: A pacing system delivers cardiac protection pacing to protect the heart from injuries associated with ischemic events. The pacing system detects an ischemic event and, in response, initiates one or more cardiac protection pacing sequences each including alternative pacing and non-pacing periods. In one embodiment, the pacing system initiates cardiac protection pacing sequences including at least one postconditioning sequence to protect the heart from a detected ischemic event and a plurality prophylactic preconditioning sequences to protect the heart from probable future ischemic events.

    Abstract translation: 起搏系统提供心脏保护起搏,以保护心脏免受与缺血事件相关的损伤。 起搏系统检测缺血事件,并作为响应启动一个或多个心脏保护起搏序列,每个起搏序列包括替代起搏和非起搏期。 在一个实施例中,起搏系统启动心脏保护起搏序列,包括至少一个后处理序列以保护心脏免受所检测的缺血事件和多个预防性预处理序列,以保护心脏免受可能的未来缺血事件。

    COLLECTING SLEEP QUALITY INFORMATION VIA A MEDICAL DEVICE
    8.
    发明申请
    COLLECTING SLEEP QUALITY INFORMATION VIA A MEDICAL DEVICE 审中-公开
    通过医疗器械收集睡眠质量信息

    公开(公告)号:US20140249605A1

    公开(公告)日:2014-09-04

    申请号:US14276516

    申请日:2014-05-13

    Abstract: At least one of a medical device, such as an implantable medical device, and a programming device determines values for one or more metrics that indicate the quality of a patient's sleep. Sleep efficiency, sleep latency, and time spent in deeper sleep states are example sleep quality metrics for which values may be determined. In some embodiments, determined sleep quality metric values are associated with a current therapy parameter set. In some embodiments, a programming device presents sleep quality information to a user based on determined sleep quality metric values. A clinician, for example, may use the sleep quality information presented by the programming device to evaluate the effectiveness of therapy delivered to the patient by the medical device, to adjust the therapy delivered by the medical device, or to prescribe a therapy not delivered by the medical device in order to improve the quality of the patient's sleep.

    Abstract translation: 诸如可植入医疗设备的医疗设备和编程设备中的至少一个确定了指示患者睡眠质量的一个或多个度量的值。 睡眠效率,睡眠延迟和在更深的睡眠状态中花费的时间是可以确定值的示例性睡眠质量度量。 在一些实施例中,确定的睡眠质量度量值与当前治疗参数组相关联。 在一些实施例中,编程设备基于确定的睡眠质量度量值向用户呈现睡眠质量信息。 例如,临床医生可以使用编程设备呈现的睡眠质量信息来评估由医疗设备递送给患者的治疗的有效性,以调整由医疗设备递送的治疗,或者开出不由 医疗器械为了提高病人的睡眠质量。

    Determining phase-specific parameters of a physiological variable
    9.
    发明授权
    Determining phase-specific parameters of a physiological variable 有权
    确定生理变量的相位参数

    公开(公告)号:US08712518B2

    公开(公告)日:2014-04-29

    申请号:US13230880

    申请日:2011-09-13

    Abstract: The invention relates to methods and systems for determining phase-specific parameters of a physiological variable, and a related computer program and a related machine-readable storage medium, which are usable in particular to determine parameters of physiological variables that are subject to circadian variation. To this end, phase-specific parameters of a physiological variable X(t) are determined by calculating, at least for a portion of values x lying in a specifiable time period, a mean g(x|τ) in each case of values X(t+τ) for which X(t)=x applies for their predecessors, τ describing a time interval, and determining the phase-specific parameters by evaluating the mean g(x|τ).

    Abstract translation: 本发明涉及用于确定生理变量的相位特定参数的方法和系统,以及相关的计算机程序和相关的机器可读存储介质,其特别可用于确定受昼夜变化影响的生理变量的参数。 为此,生理变量X(t)的相位特定参数通过至少对于指定时间段内的值x的一部分计算,在每种情况下计算值X(x |τ) (t +τ),其中X(t)= x适用于它们的前辈,τ描述时间间隔,并且通过评估平均值g(x |τ)来确定相位特定参数。

    System for providing diabetic therapy
    10.
    发明授权
    System for providing diabetic therapy 有权
    糖尿病治疗系统

    公开(公告)号:US08634930B2

    公开(公告)日:2014-01-21

    申请号:US11428070

    申请日:2006-06-30

    Abstract: Various system embodiments include a glucose control input, a low physical activity input, and a diabetic therapy delivery system adapted to respond to the glucose control input and the low physical activity input to deliver diabetic therapy. According to various embodiments, the diabetic therapy includes an anti-arrhythmia therapy, a hypertension therapy, a neural stimulation therapy adapted to reduce a risk of myocardial infarction, a neural stimulation therapy adapted to be applied after a myocardial infarction to reduce an infarct area, a neural stimulation therapy adapted to reduce a risk of sudden cardiac death, a therapy adapted to secrete insulin, or a therapy to reduce a workload of a diabetic heart. Other aspects and embodiments are provided herein.

    Abstract translation: 各种系统实施方案包括葡萄糖控制输入,低体力活动输入和适于响应于葡萄糖控制输入和低体力活动输入以递送糖尿病治疗的糖尿病治疗递送系统。 根据各种实施方案,糖尿病治疗包括抗心律失常治疗,高血压治疗,适于降低心肌梗死风险的神经刺激疗法,适于在心肌梗死后应用以减少梗死面积的神经刺激疗法, 适于减少心源性猝死的风险的神经刺激疗法,适于分泌胰岛素的治疗剂或减少糖尿病心脏的工作量的治疗方法。 本文提供了其它方面和实施例。

Patent Agency Ranking